An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain

Journal of Virology

Volumn 82, Issue 2, 2008, Pages 917-926

  Ruiz Argüello, M Begoña ^a,b   Smith, Vincent P ^a,g   Campanella, Gabriele S V ^c   Baleux, Françoise ^d   Arenzana Seisdedos, Fernando ^d   Luster, Andrew D ^c   Alcami, Antonio ^a,e,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d INSTITUT PASTEUR   (France)

^e CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^f CSIC   (Spain)

^g ILLUMINA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOSAMINOGLYCAN; STROMAL CELL DERIVED FACTOR 1; VIRULENCE FACTOR; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; CONTROLLED STUDY; ECTROMELIA VIRUS; EXTRACELLULAR MATRIX; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; LEUKOCYTE MIGRATION; MOLECULAR WEIGHT; NONHUMAN; ORTHOLOGY; PHOCOMELIA; POXVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VACCINIA VIRUS; VIRUS CHARACTERIZATION; VIRUS STRAIN;

ANIMALS; BINDING SITES; CHEMOKINES; ECTROMELIA VIRUS; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HUMANS; MICE; MUTANT PROTEINS; PROTEIN BINDING; VIRAL PROTEINS;

ECTROMELIA VIRUS; MUS; POXVIRIDAE; VACCINIA VIRUS;

EID: 37849040977     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02111-07     Document Type: Article

References (53)

1. Alcami, A. 2003. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3:36-50.
2. Alcami, A., A. Khanna, N. L. Paul, and G. L. Smith. 1999. Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J. Gen. Virol. 80:949-959.
3. Alcami, A., J. A. Symons, P. D. Collins, T. J. Williams, and G. L. Smith. 1998. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:624-633.
4. Alejo, A., M. B. Ruiz-Argüello, Y. Ho, V. P. Smith, M. Saraiva, and A. Alcami. 2006. A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc. Natl. Acad. Sci. USA 103:5995-6000.
5. Amara, A., O. Lorthioir, A. Valenzuela, A. Magerus, M. Thelen, M. Montes, J. L. Virelizier, M. Delepierre, F. Baleux, H. Lortat-Jacob, and F. Arenzana-Seisdedos. 1999. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274: 23916-23925.
6. Arnold, P. L., and D. H. Fremont. 2006. Structural determinants of chemokine binding by an ectromelia virus-encoded decoy receptor. J. Virol. 80: 7439-7449.
7. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 9:565-568.
8. Bédard, E. L., P. Kim, J. Jiang, N. Parry, L. Liu, H. Wang, B. Garcia, X. Li, G. McFadden, A. Lucas, and R. Zhong. 2003. Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76:249-252.
9. Bryant, N. A., N. Davis-Poynter, A. Vanderplasschen, and A. Alcami. 2003. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J. 22:833-846.
10. Burns, J. M., D. J. Dairaghi, M. Deitz, M. Tsang, and T. J. Schall. 2002. Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics. J. Biol. Chem. 277:2785-2789.
11. Campanella, G. S. V., E. M. J. Lee, J. Sun, and A. D. Luster. 2003. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J. Biol. Chem. 278:17066-17074.
12. Cardin, A. D., and H. J. Weintraub. 1989. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
13. Carfi, A., C. A. Smith, P. J. Smolak, J. McGrew, and D. C. Wiley. 1999. Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc. Natl. Acad. Sci. USA 96:12379-12383.
14. Chen, N., M. I. Danila, Z. Feng, R. M. Buller, C. Wang, X. Han, E. J. Lefkowitz, and C. Upton. 2003. The genomic sequence of ectromelia virus, the causative agent of mousepox. Virology 317:165-186.
15. Clark, R. H., J. C. Kenyon, N. W. Bartlett, D. C. Tscharke, and G. L. Smith. 2006. Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J. Gen. Virol. 87:29-38.
16. Crump, M. P., J. H. Gong, P. Loetscher, K. Rajarathnam, A. Amara, F. Arenzana-Seisdedos, J. L. Virelizier, M. Baggiolini, B. D. Sykes, and I. Clark-Lewis. 1997. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16:6996-7007.
17. Esteban, D. J., A. A. Nuara, and R. M. Buller. 2004. Interleukin-18 and glycosaminoglycan binding by a protein encoded by variola virus. J. Gen. Virol. 85:1291-1299.
18. Esteban, D. J., and R. M. Buller. 2005. Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86:2645-2659.
19. Fallon, P. G., and A. Alcami. 2006. Pathogen-derived immunomodulatory molecules: future immunotherapeutics? Trends Immunol. 27:470-476.
20. Finlay, B. B., and G. McFadden. 2006. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124:767-782.
21. Graham, K. A., A. S. Lalani, J. L. Macen, T. L. Ness, M. Barry, L. Y. Liu, A. Lucas, I. Clark-Lewis, R. W. Moyer, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12-24.
22. Handel, T. M., Z. Johanson, S. E. Crown, E. K. Lau, M. Sweeney, and A. E. Proudfoot. 2005. Regulation of protein function by glycosaminoglycans. As exemplified by chemokines. Annu. Rev. Biochem. 74:385-410.
23. Homey, B., H. Alenius, A. Müller, H. Soto, E. P. Bowman, W. Yuan, L. McEvoy, A. I. Lauerma, T. Assmann, E. Bünemann, M. Lento, H. Wolff, D. Yen, H. Marxhausen, W. To, J. Sedgwick, T. Ruzicka, P. Lehmann, and A. Zlotnik. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8:157-165.
24. Jensen, K. K., S. C. Chen, R. W. Hipkin, M. T. Wiekowski, M. A. Schwarz, C. C. Chou, J. P. Simas, A. Alcami, and S. A. Lira. 2003. Disruption of CCL21-induced Chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J. Virol. 77:624-630.
25. Komiya, A., H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, N. Hanai, A. Furuya, K. Ohta, K. Matsushima, O. Yoshie, K. Yamamoto, and K. Hirai. 2003. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell. Immunol. 225:91-100.
26. Kunkel, E. J., and E. C. Butcher. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16:1-4.
27. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968.
28. Lalani, A. S., K. Graham, K. Mossman, K. Rajarathnam, I. Clark-Lewis, D. Kelvin, and G. McFadden. 1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. J. Virol. 71:4356-4363.
29. Lazarus, N. H., E. J. Kunkel, B. Johnston, E. Wilson, K. R. Youngman, and E. C. Butcher. 2003. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 170:3799-3805.
30. Lucas, A., and G. McFadden. 2004. Secreted immunomodulatory viral proteins as novel biotherapeutics. J. Immunol. 173:4765-4774.
31. Martin, A. P., J. M. Alexander-Brett, C. Canasto-Chibuque, A. Garin, J. S. Bromberg, D. H. Fremont, and S. A. Lira. 2007. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin. J. Immunol. 178:4623-4631.
32. Murphy, P. M. 1996. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev. 7:47-64.
33. Murthy, K. H., S. A. Smith, V. K. Ganesh, K. W. Judge, N. Mullin, P. N. Barlow, C. M. Ogata, and G. J. Kotwal. 2001. Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell 104:301-311.
34. Ng, A., D. C. Tscharke, P. C. Reading, and G. L. Smith. 2001. The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J. Gen. Virol. 82:2095-2105.
35. Parry, C. M., J. P. Simas, V. P. Smith, C. A. Stewart, A. C. Minson, S. Efstathiou, and A. Alcami. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191:573-578.
36. Proudfoot, A. E., T. M. Handel, Z. Johnson, E. K. Lau, P. LiWang, I. Clark-Lewis, F. Borlat, T. N. Wells, and M. H. Kosco-Vilbois. 2003. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. USA 100:1885-1890.
37. Rice, J., B. de Lima, F. K. Stevenson, and P. G. Stevenson. 2002. A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur. J. Immunol. 32:3481-3487.
38. Rot, A., and U. H. von Andrian. 2004. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 22:891-928.
39. Schaerli, P., K. Willimann, L. M. Ebert, A. Walz, and B. Moser. 2005. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23:331-342.
40. Seet, B. T., C. A. McCaughan, T. M. Handel, A. Mercer, C. Brunetti, G. McFadden, and S. B. Fleming. 2003. Analysis of an orf virus chemokine-binding protein: shifting ligand specificities among a family of poxvirus viroceptors. Proc. Natl. Acad. Sci. USA 100:15137-15142.
41. Seet, B. T., J. Barrett, J. Robichaud, B. Shilton, R. Singh, and G. McFadden. 2001. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor M-T1. J. Biol. Chem. 276:30504-30513.
42. Shinkai, A., H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, T. Takeda, S. Imabeppu, Y. Kato, N. Hanai, H. Anazawa, T. Kuga, and T. Nishi. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in 1L-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J. Immunol. 163:1602-1610.
43. Smith, C. A., T. D. Smith, P. J. Smolak, D. Friend, H. Hagen, M. Gerhart, L. Park, D. J. Pickup, D. Torrance, K. Mohler, K. Schooley, and R. G. Goodwin. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316-327.
44. Smith, S. A., N. P. Mullin, J. Parkinson, S. N. Shchelkunov, A. V. Totmenin, V. N. Loparev, R. Srisatjaluk, D. N. Reynolds, K. L. Keeling, D. E. Justus, P. N. Barlow, and G. J. Kotwal. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74:5659-5666.
45. Stein, J. V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M. D. Gunn, A. Matsuzawa, E. J. Quackenbush, M. E. Dorf, and U. H. von Andrian. 2000. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191:61-76.
46. Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258:1369-1372.
47. van Berkel, V., J. Barrett, H. L. Tiffany, D. H. Fremont, P. M. Murphy, G. McFadden, S. H. Speck, and H. W. Virgin IV. 2000. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74:6741-6747.
48. Wagner, L., O. O. Yang, E. A. Garcia-Zepeda, Y. Ge, S. A. Kalams, B. D. Walker, M. S. Pasternack, and A. D. Luster. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908-911.
49. Wang, D., W. Bresnahan, and T. Shenk. 2004. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. USA 101:16642-16647.
50. Wells, T. N., C. A. Power, J. P. Shaw, and A. E. Proudfoot. 2006. Chemokine blockers - therapeutics in the making? Trends Pharmacol. Sci. 27:41-47.
51. Xiang, Y., and B. Moss. 2003. Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain. J. Virol. 77:2623-2630.
52. Zhang, L., M. Derider, M. A. McCornack, S. C. Jao, N. Isern, T. Ness, R. Moyer, and P. J. LiWang. 2006. Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta. Proc. Natl. Acad. Sci. USA 103:13985-13990.
53. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.